ONTOLOGY REPORT - ANNOTATIONS
| Term: | theophylline |
|
| Accession: | CHEBI:28177
|
browse the term
|
| Definition: | A dimethylxanthine having the two methyl groups located at positions 1 and 3. |
| Synonyms: | exact_synonym: | 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione |
| | related_synonym: | 1,3-Dimethylxanthine; 1,3-dimethyl-7H-purine-2,6-dione; C7H8N4O2; Cn1c2nc[nH]c2c(=O)n(C)c1=O; Elixophyllin; InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9); InChIKey=ZFXYFBGIUFBOJW-UHFFFAOYSA-N; Respbid; Theo-Dur; Theolair; Theophyllin; Uniphyl; theophylline anhydrous |
| | alt_id: | CHEBI:26940; CHEBI:45950; CHEBI:9523 |
| | xref_casrn: | 58-55-9 |
| | xref: | Beilstein:13463 "Beilstein Registry Number"; ChEMBL:481693 "ChEMBL COMPOUND"; ChemIDplus:58-55-9 "CAS Registry Number"; CiteXplore:10796631 "PubMed citation"; CiteXplore:10836323 "PubMed citation"; CiteXplore:10893702 "PubMed citation"; CiteXplore:10921764 "PubMed citation"; CiteXplore:11126990 "PubMed citation"; CiteXplore:11170036 "PubMed citation"; CiteXplore:11200776 "PubMed citation"; CiteXplore:11261527 "PubMed citation"; CiteXplore:11408152 "PubMed citation"; CiteXplore:11826912 "PubMed citation"; CiteXplore:11848250 "PubMed citation"; CiteXplore:11941393 "PubMed citation"; CiteXplore:11949272 "PubMed citation"; CiteXplore:11950649 "PubMed citation"; CiteXplore:12531775 "PubMed citation"; CiteXplore:12836095 "PubMed citation"; CiteXplore:14517178 "PubMed citation"; CiteXplore:14713563 "PubMed citation"; CiteXplore:14988770 "PubMed citation"; CiteXplore:15005370 "PubMed citation"; CiteXplore:15042504 "PubMed citation"; CiteXplore:15202575 "PubMed citation"; CiteXplore:15317832 "PubMed citation"; CiteXplore:15356646 "PubMed citation"; CiteXplore:15483348 "PubMed citation"; CiteXplore:15739418 "PubMed citation"; CiteXplore:15829161 "PubMed citation"; CiteXplore:15902964 "PubMed citation"; CiteXplore:15908149 "PubMed citation"; CiteXplore:16083514 "PubMed citation"; CiteXplore:16651698 "PubMed citation"; CiteXplore:16930490 "PubMed citation"; CiteXplore:17130682 "PubMed citation"; CiteXplore:17207928 "PubMed citation"; CiteXplore:18307508 "PubMed citation"; CiteXplore:18800032 "PubMed citation"; CiteXplore:19559058 "PubMed citation"; CiteXplore:19727789 "PubMed citation"; CiteXplore:19845735 "PubMed citation"; CiteXplore:19888960 "PubMed citation"; CiteXplore:21467671 "PubMed citation"; CiteXplore:21796703 "PubMed citation"; CiteXplore:21834615 "PubMed citation"; CiteXplore:22377744 "PubMed citation"; CiteXplore:22541679 "PubMed citation"; CiteXplore:22541837 "PubMed citation"; CiteXplore:22702215 "PubMed citation"; CiteXplore:22770225 "PubMed citation"; CiteXplore:22771369 "PubMed citation"; CiteXplore:22836872 "PubMed citation"; CiteXplore:22909172 "PubMed citation"; CiteXplore:22915350 "PubMed citation"; CiteXplore:22981724 "PubMed citation"; CiteXplore:7302609 "PubMed citation"; CiteXplore:7389811 "PubMed citation"; CiteXplore:7656958 "PubMed citation"; CiteXplore:7767539 "PubMed citation"; CiteXplore:8730732 "PubMed citation"; CiteXplore:8960878 "PubMed citation"; CiteXplore:9256615 "PubMed citation"; DrugBank:DB00277 "DrugBank"; Gmelin:51226 "Gmelin Registry Number"; HMDB:HMDB01889 "HMDB"; KEGG COMPOUND:58-55-9 "CAS Registry Number"; KEGG COMPOUND:C07130 "KEGG COMPOUND"; KEGG DRUG:D00371 "KEGG DRUG" |
| | xref_mesh: | MESH:D013806 |
| | xref: | MetaCyc:CPD-12479 "MetaCyc"; NIST Chemistry WebBook:58-55-9 "CAS Registry Number"; PDBeChem:TEP "PDBeChem"; Reaxys:13463 "Reaxys Registry Number"; Wikipedia:Theophylline "Wikipedia" |
|
|
theophylline
|
| G |
4930590J08Rik |
RIKEN cDNA 4930590J08 gene |
|
multiple interactions |
ISO |
6 |
91,854,227 |
91,900,719 |
RGD:6480464 |
CTD |
| G |
4933411K20Rik |
RIKEN cDNA 4933411K20 gene |
|
increases expression |
ISO |
8 |
47,254,910 |
47,280,944 |
RGD:6480464 |
CTD |
| G |
4933434E20Rik |
RIKEN cDNA 4933434E20 gene |
|
multiple interactions |
ISO |
3 |
89,856,739 |
89,866,369 |
RGD:6480464 |
CTD |
| G |
9030624J02Rik |
RIKEN cDNA 9030624J02 gene |
|
multiple interactions |
ISO |
7 |
125,883,785 |
125,985,005 |
RGD:6480464 |
CTD |
| G |
Abhd11 |
abhydrolase domain containing 11 |
|
multiple interactions |
ISO |
5 |
135,485,022 |
135,488,045 |
RGD:6480464 |
CTD |
| G |
Abl2 |
v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene) |
|
decreases expression |
ISO |
1 |
158,488,918 |
158,579,750 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
increases activity |
ISO |
6 |
48,845,254 |
48,859,186 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
decreases expression |
ISO |
6 |
48,845,254 |
48,859,186 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
multiple interactions |
ISO |
9 |
119,250,412 |
119,259,413 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
|
decreases expression |
ISO |
3 |
153,585,323 |
153,607,396 |
RGD:6480464 |
CTD |
| G |
Acot7 |
acyl-CoA thioesterase 7 |
|
multiple interactions |
ISO |
4 |
151,552,209 |
151,645,964 |
RGD:6480464 |
CTD |
| G |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
|
multiple interactions |
ISO |
19 |
34,315,581 |
34,329,826 |
RGD:6480464 |
CTD |
| G |
Actr2 |
ARP2 actin-related protein 2 |
|
decreases expression |
ISO |
11 |
19,962,307 |
20,012,954 |
RGD:6480464 |
CTD |
| G |
Actr3 |
ARP3 actin-related protein 3 |
|
decreases expression |
ISO |
1 |
127,289,483 |
127,332,067 |
RGD:6480464 |
CTD |
| G |
Adad1 |
adenosine deaminase domain containing 1 (testis specific) |
|
decreases expression |
ISO |
3 |
36,962,578 |
37,010,434 |
RGD:6480464 |
CTD |
| G |
Adamtsl3 |
ADAMTS-like 3 |
|
multiple interactions |
ISO |
7 |
89,484,204 |
89,762,958 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
ISO |
1 |
136,095,799 |
136,132,008 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
decreases activity |
ISO |
1 |
136,095,799 |
136,132,008 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
ISO |
1 |
136,095,799 |
136,132,008 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
decreases expression |
ISO |
1 |
136,095,799 |
136,132,008 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
ISO |
1 |
136,095,799 |
136,132,008 |
RGD:6480464 |
CTD |
| G |
Adrbk2 |
adrenergic receptor kinase, beta 2 |
|
multiple interactions |
ISO |
5 |
113,339,498 |
113,444,534 |
RGD:6480464 |
CTD |
| G |
Adrbk2 |
adrenergic receptor kinase, beta 2 |
|
decreases expression |
ISO |
5 |
113,339,498 |
113,444,534 |
RGD:6480464 |
CTD |
| G |
Aff4 |
AF4/FMR2 family, member 4 |
|
multiple interactions |
ISO |
11 |
53,164,269 |
53,235,332 |
RGD:6480464 |
CTD |
| G |
Agfg1 |
ArfGAP with FG repeats 1 |
|
increases expression |
ISO |
1 |
82,836,058 |
82,892,850 |
RGD:6480464 |
CTD |
| G |
Ahctf1 |
AT hook containing transcription factor 1 |
|
multiple interactions |
ISO |
1 |
181,675,035 |
181,734,146 |
RGD:6480464 |
CTD |
| G |
Akt1s1 |
AKT1 substrate 1 (proline-rich) |
|
increases expression |
ISO |
7 |
52,104,597 |
52,110,780 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
decreases expression |
ISO |
11 |
78,137,700 |
78,140,262 |
RGD:6480464 |
CTD |
| G |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
|
multiple interactions |
ISO |
9 |
50,583,435 |
50,651,633 |
RGD:6480464 |
CTD |
| G |
Ankdd1a |
ankyrin repeat and death domain containing 1A |
|
increases expression |
ISO |
9 |
65,349,791 |
65,368,000 |
RGD:6480464 |
CTD |
| G |
Ankrd13c |
ankyrin repeat domain 13c |
|
multiple interactions |
ISO |
3 |
157,610,430 |
157,669,801 |
RGD:6480464 |
CTD |
| G |
Ankrd44 |
ankyrin repeat domain 44 |
|
increases expression |
ISO |
1 |
54,702,184 |
54,983,231 |
RGD:6480464 |
CTD |
| G |
Apex1 |
apurinic/apyrimidinic endonuclease 1 |
|
decreases expression |
ISO |
14 |
51,544,696 |
51,546,813 |
RGD:6480464 |
CTD |
| G |
Arf1 |
ADP-ribosylation factor 1 |
|
multiple interactions |
ISO |
11 |
59,024,914 |
59,041,769 |
RGD:6480464 |
CTD |
| G |
Arhgap15 |
Rho GTPase activating protein 15 |
|
increases expression |
ISO |
2 |
43,604,344 |
44,243,143 |
RGD:6480464 |
CTD |
| G |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
|
multiple interactions |
ISO |
15 |
96,117,953 |
96,235,894 |
RGD:6480464 |
CTD |
| G |
Armc8 |
armadillo repeat containing 8 |
|
multiple interactions |
ISO |
9 |
99,378,810 |
99,469,318 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions |
ISO |
3 |
95,238,312 |
95,301,162 |
RGD:6480464 |
CTD |
| G |
Arsb |
arylsulfatase B |
|
multiple interactions |
ISO |
13 |
94,541,634 |
94,712,971 |
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
decreases expression |
ISO |
5 |
130,487,373 |
130,500,201 |
RGD:6480464 |
CTD |
| G |
Atg3 |
autophagy related 3 |
|
increases expression |
ISO |
16 |
45,158,942 |
45,188,651 |
RGD:6480464 |
CTD |
| G |
Atp5s |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s |
|
decreases expression |
ISO |
12 |
70,825,949 |
70,845,645 |
RGD:6480464 |
CTD |
| G |
Atpaf2 |
ATP synthase mitochondrial F1 complex assembly factor 2 |
|
multiple interactions |
ISO |
11 |
60,214,126 |
60,230,601 |
RGD:6480464 |
CTD |
| G |
Atrx |
alpha thalassemia/mental retardation syndrome X-linked homolog (human) |
|
multiple interactions |
ISO |
X |
102,992,954 |
103,124,711 |
RGD:6480464 |
CTD |
| G |
AU019823 |
expressed sequence AU019823 |
|
increases expression |
ISO |
9 |
50,413,345 |
50,425,569 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
multiple interactions |
ISO |
11 |
68,859,145 |
68,865,164 |
RGD:6480464 |
CTD |
| G |
Azi2 |
5-azacytidine induced gene 2 |
|
multiple interactions |
ISO |
9 |
117,949,617 |
117,973,025 |
RGD:6480464 |
CTD |
| G |
Azi2 |
5-azacytidine induced gene 2 |
|
decreases expression |
ISO |
9 |
117,949,617 |
117,973,025 |
RGD:6480464 |
CTD |
| G |
B4galt7 |
xylosylprotein beta1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) |
|
multiple interactions |
ISO |
13 |
55,701,472 |
55,711,315 |
RGD:6480464 |
CTD |
| G |
Bag5 |
BCL2-associated athanogene 5 |
|
multiple interactions |
ISO |
12 |
112,947,699 |
112,951,467 |
RGD:6480464 |
CTD |
| G |
BC030336 |
cDNA sequence BC030336 |
|
increases expression |
ISO |
7 |
127,821,134 |
127,878,368 |
RGD:6480464 |
CTD |
| G |
BC053749 |
cDNA sequence BC053749 |
|
increases expression |
ISO |
7 |
31,324,153 |
31,337,291 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl7c |
B cell CLL/lymphoma 7C |
|
multiple interactions |
ISO |
7 |
134,848,492 |
134,852,280 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
increases expression |
ISO |
10 |
74,523,641 |
74,647,668 |
RGD:6480464 |
CTD |
| G |
Blnk |
B cell linker |
|
increases expression |
ISO |
19 |
41,003,417 |
41,069,025 |
RGD:6480464 |
CTD |
| G |
Braf |
Braf transforming gene |
|
multiple interactions |
ISO |
6 |
39,553,236 |
39,675,462 |
RGD:6480464 |
CTD |
| G |
Bre |
brain and reproductive organ-expressed protein |
|
multiple interactions |
ISO |
5 |
32,000,423 |
32,387,112 |
RGD:6480464 |
CTD |
| G |
Btbd10 |
BTB (POZ) domain containing 10 |
|
increases expression |
ISO |
7 |
120,459,158 |
120,512,853 |
RGD:6480464 |
CTD |
| G |
Btg3 |
B cell translocation gene 3 |
|
multiple interactions |
ISO |
16 |
78,360,105 |
78,377,030 |
RGD:6480464 |
CTD |
| G |
C2cd5 |
C2 calcium-dependent domain containing 5 |
|
multiple interactions |
ISO |
6 |
142,959,440 |
143,048,627 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
increases expression |
ISO |
6 |
29,298,119 |
29,326,675 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
increases expression |
ISO |
6 |
29,298,119 |
29,326,675 |
RGD:6480464 |
CTD |
| G |
Camk2d |
calcium/calmodulin-dependent protein kinase II, delta |
|
decreases expression |
ISO |
3 |
126,299,891 |
126,547,972 |
RGD:6480464 |
CTD |
| G |
Cand1 |
cullin associated and neddylation disassociated 1 |
|
multiple interactions |
ISO |
10 |
118,635,868 |
118,677,111 |
RGD:6480464 |
CTD |
| G |
Caprin1 |
cell cycle associated protein 1 |
|
increases expression |
ISO |
2 |
103,603,102 |
103,637,797 |
RGD:6480464 |
CTD |
| G |
Capza1 |
capping protein (actin filament) muscle Z-line, alpha 1 |
|
decreases expression |
ISO |
3 |
104,625,703 |
104,667,423 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
multiple interactions |
ISO |
6 |
42,215,038 |
42,232,495 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Ccdc130 |
coiled-coil domain containing 130 |
|
multiple interactions |
ISO |
8 |
86,781,694 |
86,794,259 |
RGD:6480464 |
CTD |
| G |
Ccdc181 |
coiled-coil domain containing 181 |
|
decreases expression |
ISO |
1 |
166,205,729 |
166,217,978 |
RGD:6480464 |
CTD |
| G |
Ccdc30 |
coiled-coil domain containing 30 |
|
multiple interactions |
ISO |
4 |
118,996,444 |
119,088,126 |
RGD:6480464 |
CTD |
| G |
Ccdc82 |
coiled-coil domain containing 82 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccdc93 |
coiled-coil domain containing 93 |
|
multiple interactions |
ISO |
1 |
123,327,644 |
123,403,037 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Cd33 |
CD33 antigen |
|
multiple interactions |
ISO |
7 |
50,782,826 |
50,788,541 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
decreases expression |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd4 |
CD4 antigen |
|
decreases expression |
ISO |
6 |
124,814,711 |
124,838,227 |
RGD:6480464 |
CTD |
| G |
Cdk13 |
cyclin-dependent kinase 13 |
|
multiple interactions |
ISO |
13 |
17,807,796 |
17,896,931 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 |
|
decreases expression |
ISO |
7 |
26,246,721 |
26,262,644 |
RGD:6480464 |
CTD |
| G |
Cep63 |
centrosomal protein 63 |
|
multiple interactions |
ISO |
9 |
102,488,908 |
102,528,454 |
RGD:6480464 |
CTD |
| G |
Cept1 |
choline/ethanolaminephosphotransferase 1 |
|
multiple interactions |
ISO |
3 |
106,305,178 |
106,350,679 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha subunit |
|
multiple interactions |
ISO |
4 |
34,841,028 |
34,854,623 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha subunit |
|
multiple interactions |
ISO |
4 |
34,841,028 |
34,854,623 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha subunit |
|
multiple interactions |
ISO |
4 |
34,841,028 |
34,854,623 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha subunit |
|
increases expression |
ISO |
4 |
34,841,028 |
34,854,623 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha subunit |
|
increases stability |
ISO |
4 |
34,841,028 |
34,854,623 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha subunit |
|
multiple interactions |
ISO |
4 |
34,841,028 |
34,854,623 |
RGD:6480464 |
CTD |
| G |
Clec16a |
C-type lectin domain family 16, member A |
|
decreases expression |
ISO |
16 |
10,545,480 |
10,744,964 |
RGD:6480464 |
CTD |
| G |
Clec4f |
C-type lectin domain family 4, member f |
|
decreases expression |
ISO |
6 |
83,594,536 |
83,606,110 |
RGD:6480464 |
CTD |
| G |
Clpb |
ClpB caseinolytic peptidase B |
|
multiple interactions |
ISO |
7 |
108,812,282 |
108,938,682 |
RGD:6480464 |
CTD |
| G |
Clpb |
ClpB caseinolytic peptidase B |
|
increases expression |
ISO |
7 |
108,812,282 |
108,938,682 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
11 |
94,797,584 |
94,813,181 |
RGD:6480464 |
CTD |
| G |
Coq4 |
coenzyme Q4 homolog (yeast) |
|
multiple interactions |
ISO |
2 |
29,643,783 |
29,653,263 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
multiple interactions |
ISO |
1 |
36,748,332 |
36,750,233 |
RGD:6480464 |
CTD |
| G |
Cpm |
carboxypeptidase M |
|
multiple interactions |
ISO |
10 |
117,066,556 |
117,124,408 |
RGD:6480464 |
CTD |
| G |
Cpne1 |
copine I |
|
affects binding |
ISO |
2 |
155,897,577 |
155,937,701 |
RGD:6480464 |
CTD |
| G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
|
multiple interactions |
ISO |
6 |
113,433,563 |
113,443,332 |
RGD:6480464 |
CTD |
| G |
Crtc3 |
CREB regulated transcription coactivator 3 |
|
multiple interactions |
ISO |
7 |
87,731,518 |
87,833,763 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
decreases expression |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
ISO |
11 |
98,562,627 |
98,564,943 |
RGD:6480464 |
CTD |
| G |
Csnk1e |
casein kinase 1, epsilon |
|
multiple interactions |
ISO |
15 |
79,248,282 |
79,272,487 |
RGD:6480464 |
CTD |
| G |
Ctps |
cytidine 5'-triphosphate synthase |
|
decreases expression |
ISO |
4 |
120,212,473 |
120,242,881 |
RGD:6480464 |
CTD |
| G |
Ctrl |
chymotrypsin-like |
|
increases expression |
ISO |
8 |
108,455,894 |
108,457,762 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases expression |
ISO |
14 |
63,741,302 |
63,764,758 |
RGD:6480464 |
CTD |
| G |
Ctsl |
cathepsin L |
|
decreases expression |
ISO |
13 |
64,464,522 |
64,471,614 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
EXP |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects hydroxylation |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects response to substance |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases chemical synthesis |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp2d9 |
cytochrome P450, family 2, subfamily d, polypeptide 9 |
|
decreases expression |
ISO |
15 |
82,282,807 |
82,287,257 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects hydroxylation |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases chemical synthesis |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
multiple interactions |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
decreases expression |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Dab2 |
disabled 2, mitogen-responsive phosphoprotein |
|
multiple interactions |
ISO |
15 |
6,249,789 |
6,390,712 |
RGD:6480464 |
CTD |
| G |
Dact3 |
dapper homolog 3, antagonist of beta-catenin (xenopus) |
|
multiple interactions |
ISO |
7 |
17,460,666 |
17,472,650 |
RGD:6480464 |
CTD |
| G |
Dcbld1 |
discoidin, CUB and LCCL domain containing 1 |
|
multiple interactions |
ISO |
10 |
51,953,425 |
52,041,183 |
RGD:6480464 |
CTD |
| G |
Ddi2 |
DNA-damage inducible protein 2 |
|
multiple interactions |
ISO |
4 |
141,239,478 |
141,279,334 |
RGD:6480464 |
CTD |
| G |
Dhx8 |
DEAH (Asp-Glu-Ala-His) box polypeptide 8 |
|
multiple interactions |
ISO |
11 |
101,594,270 |
101,628,672 |
RGD:6480464 |
CTD |
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
16 |
31,664,125 |
31,873,432 |
RGD:6480464 |
CTD |
| G |
Dnajc15 |
DnaJ (Hsp40) homolog, subfamily C, member 15 |
|
multiple interactions |
ISO |
14 |
78,226,024 |
78,274,724 |
RGD:6480464 |
CTD |
| G |
Dnajc4 |
DnaJ (Hsp40) homolog, subfamily C, member 4 |
|
multiple interactions |
ISO |
19 |
7,062,401 |
7,066,762 |
RGD:6480464 |
CTD |
| G |
Dock4 |
dedicator of cytokinesis 4 |
|
multiple interactions |
ISO |
12 |
41,172,640 |
41,573,082 |
RGD:6480464 |
CTD |
| G |
Dolk |
dolichol kinase |
|
multiple interactions |
ISO |
2 |
30,139,749 |
30,141,874 |
RGD:6480464 |
CTD |
| G |
Drd5 |
dopamine receptor D5 |
|
increases expression |
ISO |
5 |
38,710,748 |
38,713,549 |
RGD:6480464 |
CTD |
| G |
Dusp19 |
dual specificity phosphatase 19 |
|
multiple interactions |
ISO |
2 |
80,457,371 |
80,471,818 |
RGD:6480464 |
CTD |
| G |
Ears2 |
glutamyl-tRNA synthetase 2 (mitochondrial)(putative) |
|
increases expression |
ISO |
7 |
129,182,335 |
129,210,577 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
multiple interactions |
ISO |
12 |
55,279,968 |
55,304,861 |
RGD:6480464 |
CTD |
| G |
Eif2s3x |
eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked |
|
increases expression |
ISO |
X |
91,434,048 |
91,457,990 |
RGD:6480464 |
CTD |
| G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
|
increases expression |
ISO |
19 |
60,837,019 |
60,866,596 |
RGD:6480464 |
CTD |
| G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
|
increases expression |
ISO |
5 |
140,895,259 |
140,919,312 |
RGD:6480464 |
CTD |
| G |
Eif3e |
eukaryotic translation initiation factor 3, subunit E |
|
decreases expression |
ISO |
15 |
43,081,586 |
43,114,282 |
RGD:6480464 |
CTD |
| G |
Eif4b |
eukaryotic translation initiation factor 4B |
|
increases expression |
ISO |
15 |
101,904,204 |
101,927,604 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
decreases expression |
ISO |
12 |
112,776,312 |
112,784,964 |
RGD:6480464 |
CTD |
| G |
Elp6 |
elongator acetyltransferase complex subunit 6 |
|
multiple interactions |
ISO |
9 |
110,207,696 |
110,224,606 |
RGD:6480464 |
CTD |
| G |
Emc3 |
ER membrane protein complex subunit 3 |
|
multiple interactions |
ISO |
6 |
113,464,881 |
113,481,632 |
RGD:6480464 |
CTD |
| G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
|
multiple interactions |
ISO |
12 |
85,714,807 |
85,749,979 |
RGD:6480464 |
CTD |
| G |
Epg5 |
ectopic P-granules autophagy protein 5 homolog (C. elegans) |
|
multiple interactions |
ISO |
18 |
78,135,212 |
78,231,766 |
RGD:6480464 |
CTD |
| G |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
|
decreases expression |
ISO |
4 |
108,952,880 |
109,060,422 |
RGD:6480464 |
CTD |
| G |
Eps8l1 |
EPS8-like 1 |
|
multiple interactions |
ISO |
7 |
4,416,344 |
4,430,844 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
multiple interactions |
ISO |
1 |
44,204,589 |
44,238,105 |
RGD:6480464 |
CTD |
| G |
Erf |
Ets2 repressor factor |
|
multiple interactions |
ISO |
7 |
26,027,579 |
26,035,777 |
RGD:6480464 |
CTD |
| G |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
|
multiple interactions |
ISO |
17 |
26,698,457 |
26,793,879 |
RGD:6480464 |
CTD |
| G |
Erlin1 |
ER lipid raft associated 1 |
|
multiple interactions |
ISO |
19 |
44,109,433 |
44,144,275 |
RGD:6480464 |
CTD |
| G |
Erlin2 |
ER lipid raft associated 2 |
|
multiple interactions |
ISO |
8 |
28,134,331 |
28,149,896 |
RGD:6480464 |
CTD |
| G |
Evi2b |
ecotropic viral integration site 2b |
|
decreases expression |
ISO |
11 |
79,326,887 |
79,344,091 |
RGD:6480464 |
CTD |
| G |
Exosc3 |
exosome component 3 |
|
multiple interactions |
ISO |
4 |
45,329,501 |
45,333,475 |
RGD:6480464 |
CTD |
| G |
Exosc4 |
exosome component 4 |
|
multiple interactions |
ISO |
15 |
76,157,827 |
76,161,100 |
RGD:6480464 |
CTD |
| G |
Eya3 |
eyes absent 3 homolog (Drosophila) |
|
increases expression |
ISO |
4 |
132,194,961 |
132,280,678 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
ISO |
6 |
71,149,882 |
71,155,017 |
RGD:6480464 |
CTD |
| G |
Fads3 |
fatty acid desaturase 3 |
|
multiple interactions |
ISO |
19 |
10,116,038 |
10,134,161 |
RGD:6480464 |
CTD |
| G |
Fam222b |
family with sequence similarity 222, member B |
|
multiple interactions |
ISO |
11 |
77,908,175 |
77,970,841 |
RGD:6480464 |
CTD |
| G |
Fbxo8 |
F-box protein 8 |
|
multiple interactions |
ISO |
8 |
59,029,931 |
59,072,736 |
RGD:6480464 |
CTD |
| G |
Fchsd2 |
FCH and double SH3 domains 2 |
|
multiple interactions |
ISO |
7 |
108,257,289 |
108,432,919 |
RGD:6480464 |
CTD |
| G |
Fdxr |
ferredoxin reductase |
|
multiple interactions |
ISO |
11 |
115,129,339 |
115,138,283 |
RGD:6480464 |
CTD |
| G |
Fga |
fibrinogen alpha chain |
|
increases expression |
ISO |
3 |
82,830,075 |
82,837,549 |
RGD:6480464 |
CTD |
| G |
Fgb |
fibrinogen beta chain |
|
increases expression |
ISO |
3 |
82,846,225 |
82,853,712 |
RGD:6480464 |
CTD |
| G |
Fhl3 |
four and a half LIM domains 3 |
|
multiple interactions |
ISO |
4 |
124,377,943 |
124,385,855 |
RGD:6480464 |
CTD |
| G |
Fibp |
fibroblast growth factor (acidic) intracellular binding protein |
|
multiple interactions |
ISO |
19 |
5,460,694 |
5,464,994 |
RGD:6480464 |
CTD |
| G |
Fip1l1 |
FIP1 like 1 (S. cerevisiae) |
|
multiple interactions |
ISO |
5 |
74,931,507 |
74,993,149 |
RGD:6480464 |
CTD |
| G |
Fitm2 |
fat storage-inducing transmembrane protein 2 |
|
multiple interactions |
ISO |
2 |
163,294,439 |
163,298,365 |
RGD:6480464 |
CTD |
| G |
Flot2 |
flotillin 2 |
|
multiple interactions |
ISO |
11 |
77,851,443 |
77,873,934 |
RGD:6480464 |
CTD |
| G |
Fnbp4 |
formin binding protein 4 |
|
multiple interactions |
ISO |
2 |
90,585,527 |
90,621,178 |
RGD:6480464 |
CTD |
| G |
Fntb |
farnesyltransferase, CAAX box, beta |
|
multiple interactions |
ISO |
12 |
77,938,454 |
78,022,399 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
multiple interactions |
ISO |
7 |
109,006,845 |
109,019,197 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Foxf2 |
forkhead box F2 |
|
multiple interactions |
ISO |
13 |
31,717,685 |
31,723,275 |
RGD:6480464 |
CTD |
| G |
Foxk2 |
forkhead box K2 |
|
increases expression |
ISO |
11 |
121,121,301 |
121,171,210 |
RGD:6480464 |
CTD |
| G |
Fsd1l |
fibronectin type III and SPRY domain containing 1-like |
|
increases expression |
ISO |
4 |
53,644,427 |
53,664,491 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
|
multiple interactions |
ISO |
6 |
129,483,210 |
129,492,349 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 |
|
multiple interactions |
EXP |
11 |
41,944,982 |
41,996,432 |
RGD:6480464 |
CTD |
| G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
|
multiple interactions |
EXP |
11 |
42,233,259 |
42,446,093 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
|
multiple interactions |
EXP |
11 |
41,723,697 |
41,814,180 |
RGD:6480464 |
CTD |
| G |
Gabrr2 |
gamma-aminobutyric acid (GABA) C receptor, subunit rho 2 |
|
multiple interactions |
ISO |
4 |
33,150,087 |
33,182,840 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
increases expression |
ISO |
11 |
5,800,826 |
5,849,602 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
multiple interactions |
ISO |
8 |
73,153,293 |
73,155,534 |
RGD:6480464 |
CTD |
| G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
|
increases expression |
ISO |
6 |
86,992,840 |
87,042,201 |
RGD:6480464 |
CTD |
| G |
Ggps1 |
geranylgeranyl diphosphate synthase 1 |
|
multiple interactions |
ISO |
13 |
14,144,712 |
14,155,668 |
RGD:6480464 |
CTD |
| G |
Gkap1 |
G kinase anchoring protein 1 |
|
increases expression |
ISO |
13 |
58,334,712 |
58,375,549 |
RGD:6480464 |
CTD |
| G |
Glrx3 |
glutaredoxin 3 |
|
increases expression |
ISO |
7 |
144,629,331 |
144,660,277 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
multiple interactions |
ISO |
1 |
52,220,293 |
52,290,076 |
RGD:6480464 |
CTD |
| G |
Gm12597 |
predicted gene 12597 |
|
decreases metabolic processing |
ISO |
4 |
88,203,577 |
88,204,149 |
RGD:6480464 |
CTD |
| G |
Gm3608 |
predicted gene 3608 |
|
decreases expression |
ISO |
1 |
107,352,518 |
107,355,475 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting 1 |
|
decreases expression |
ISO |
5 |
17,770,953 |
17,866,231 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting 1 |
|
increases expression |
ISO |
5 |
17,770,953 |
17,866,231 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
|
decreases expression |
ISO |
9 |
107,516,469 |
107,537,673 |
RGD:6480464 |
CTD |
| G |
Gnaq |
guanine nucleotide binding protein, alpha q polypeptide |
|
decreases expression |
ISO |
19 |
16,207,321 |
16,461,943 |
RGD:6480464 |
CTD |
| G |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
|
decreases expression |
ISO |
2 |
174,109,821 |
174,172,245 |
RGD:6480464 |
CTD |
| G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta 1 |
|
multiple interactions |
ISO |
4 |
154,865,470 |
154,933,378 |
RGD:6480464 |
CTD |
| G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta 1 |
|
decreases expression |
ISO |
4 |
154,865,470 |
154,933,378 |
RGD:6480464 |
CTD |
| G |
Gpatch8 |
G patch domain containing 8 |
|
multiple interactions |
ISO |
11 |
102,337,229 |
102,417,472 |
RGD:6480464 |
CTD |
| G |
Gpm6a |
glycoprotein m6a |
|
increases expression |
ISO |
8 |
56,040,081 |
56,146,231 |
RGD:6480464 |
CTD |
| G |
Gpr137c |
G protein-coupled receptor 137C |
|
increases expression |
ISO |
14 |
45,839,392 |
45,900,651 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Grm1 |
glutamate receptor, metabotropic 1 |
|
decreases expression |
ISO |
10 |
10,408,551 |
10,802,129 |
RGD:6480464 |
CTD |
| G |
Grm6 |
glutamate receptor, metabotropic 6 |
|
multiple interactions |
ISO |
11 |
50,664,187 |
50,679,710 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase, mu 2 |
|
decreases expression |
ISO |
3 |
107,784,620 |
107,789,354 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase, mu 3 |
|
decreases expression |
ISO |
3 |
107,766,614 |
107,772,076 |
RGD:6480464 |
CTD |
| G |
Gtpbp5 |
GTP binding protein 5 |
|
multiple interactions |
ISO |
2 |
179,805,298 |
179,820,607 |
RGD:6480464 |
CTD |
| G |
H13 |
histocompatibility 13 |
|
affects binding |
ISO |
2 |
152,495,197 |
152,534,404 |
RGD:6480464 |
CTD |
| G |
Hadh |
hydroxyacyl-Coenzyme A dehydrogenase |
|
decreases expression |
ISO |
3 |
130,936,342 |
130,974,955 |
RGD:6480464 |
CTD |
| G |
Hc |
hemolytic complement |
|
multiple interactions |
ISO |
2 |
34,838,851 |
34,916,961 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
increases expression |
ISO |
4 |
129,193,348 |
129,219,890 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
increases activity |
ISO |
4 |
129,193,348 |
129,219,890 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
increases expression |
ISO |
4 |
129,193,348 |
129,219,890 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
increases expression |
ISO |
4 |
129,193,348 |
129,219,890 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
increases expression |
ISO |
10 |
36,694,350 |
36,721,694 |
RGD:6480464 |
CTD |
| G |
Hdac3 |
histone deacetylase 3 |
|
increases activity |
ISO |
18 |
38,096,625 |
38,114,642 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
affects response to substance |
EXP |
2 |
126,419,404 |
126,444,401 |
RGD:6480464 |
CTD |
| G |
Helq |
helicase, POLQ-like |
|
multiple interactions |
ISO |
5 |
101,191,167 |
101,227,619 |
RGD:6480464 |
CTD |
| G |
Hemk1 |
HemK methyltransferase family member 1 |
|
multiple interactions |
ISO |
9 |
107,229,413 |
107,240,681 |
RGD:6480464 |
CTD |
| G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
|
decreases expression |
ISO |
6 |
52,496,224 |
52,590,294 |
RGD:6480464 |
CTD |
| G |
Hint1 |
histidine triad nucleotide binding protein 1 |
|
multiple interactions |
ISO |
11 |
54,679,940 |
54,683,998 |
RGD:6480464 |
CTD |
| G |
Hist1h2ak |
histone cluster 1, H2ak |
|
decreases expression |
ISO |
13 |
21,845,304 |
21,845,696 |
RGD:6480464 |
CTD |
| G |
Hist1h3e |
histone cluster 1, H3e |
|
multiple interactions |
ISO |
13 |
23,653,824 |
23,654,234 |
RGD:6480464 |
CTD |
| G |
Hist2h2aa1 |
histone cluster 2, H2aa1 |
|
multiple interactions |
ISO |
3 |
96,043,639 |
96,044,216 |
RGD:6480464 |
CTD |
| G |
Hist4h4 |
histone cluster 4, H4 |
|
multiple interactions |
ISO |
6 |
136,752,589 |
136,752,900 |
RGD:6480464 |
CTD |
| G |
Hnrnph3 |
heterogeneous nuclear ribonucleoprotein H3 |
|
multiple interactions |
ISO |
10 |
62,477,412 |
62,486,597 |
RGD:6480464 |
CTD |
| G |
Hps4 |
Hermansky-Pudlak syndrome 4 homolog (human) |
|
decreases expression |
ISO |
5 |
112,772,115 |
112,807,444 |
RGD:6480464 |
CTD |
| G |
Hspa2 |
heat shock protein 2 |
|
increases expression |
ISO |
12 |
77,505,163 |
77,507,925 |
RGD:6480464 |
CTD |
| G |
Htra2 |
HtrA serine peptidase 2 |
|
multiple interactions |
ISO |
6 |
83,001,260 |
83,004,565 |
RGD:6480464 |
CTD |
| G |
Hus1 |
Hus1 homolog (S. pombe) |
|
decreases expression |
ISO |
11 |
8,893,145 |
8,911,140 |
RGD:6480464 |
CTD |
| G |
Icam4 |
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
|
multiple interactions |
ISO |
9 |
20,833,817 |
20,834,975 |
RGD:6480464 |
CTD |
| G |
Idua |
iduronidase, alpha-L- |
|
multiple interactions |
ISO |
5 |
109,098,125 |
109,113,577 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
multiple interactions |
ISO |
8 |
87,185,230 |
87,186,751 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ift122 |
intraflagellar transport 122 |
|
multiple interactions |
ISO |
6 |
115,803,546 |
115,876,717 |
RGD:6480464 |
CTD |
| G |
Ift57 |
intraflagellar transport 57 |
|
multiple interactions |
ISO |
16 |
49,699,407 |
49,765,239 |
RGD:6480464 |
CTD |
| G |
Ift88 |
intraflagellar transport 88 |
|
multiple interactions |
ISO |
14 |
58,042,908 |
58,136,773 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
decreases expression |
ISO |
1 |
72,904,639 |
72,921,439 |
RGD:6480464 |
CTD |
| G |
Ihh |
Indian hedgehog |
|
increases expression |
ISO |
1 |
74,991,892 |
74,998,225 |
RGD:6480464 |
CTD |
| G |
Ikbip |
IKBKB interacting protein |
|
multiple interactions |
ISO |
10 |
90,545,784 |
90,565,358 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases secretion |
EXP |
1 |
132,916,422 |
132,921,547 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12a |
|
multiple interactions |
ISO |
3 |
68,494,566 |
68,502,469 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12b |
|
multiple interactions |
ISO |
11 |
44,213,565 |
44,227,519 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12b |
|
decreases expression |
ISO |
11 |
44,213,565 |
44,227,519 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
decreases expression |
ISO |
11 |
53,444,825 |
53,448,204 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
decreases secretion |
ISO |
11 |
53,444,825 |
53,448,204 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
ISO |
9 |
50,373,473 |
50,389,942 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases secretion |
EXP |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha chain |
|
decreases expression |
ISO |
2 |
11,564,419 |
11,614,821 |
RGD:6480464 |
CTD |
| G |
Il3 |
interleukin 3 |
|
decreases expression |
ISO |
11 |
54,078,587 |
54,080,781 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases secretion |
EXP |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
ISO |
11 |
53,425,962 |
53,432,167 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6ra |
interleukin 6 receptor, alpha |
|
decreases expression |
ISO |
3 |
89,673,246 |
89,717,084 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
increases expression |
ISO |
13 |
113,254,278 |
113,297,068 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
decreases expression |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Ilk |
integrin linked kinase |
|
multiple interactions |
ISO |
7 |
112,885,104 |
112,891,439 |
RGD:6480464 |
CTD |
| G |
Inip |
INTS3 and NABP interacting protein |
|
multiple interactions |
ISO |
4 |
59,782,514 |
59,796,727 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
ISO |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
decreases expression |
ISO |
7 |
148,449,088 |
148,452,300 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
increases expression |
ISO |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Itfg1 |
integrin alpha FG-GAP repeat containing 1 |
|
multiple interactions |
ISO |
8 |
88,241,456 |
88,364,848 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin alpha M |
|
multiple interactions |
ISO |
7 |
135,206,154 |
135,262,005 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin beta 2 |
|
increases expression |
ISO |
10 |
76,993,093 |
77,028,419 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
multiple interactions |
ISO |
14 |
73,736,789 |
73,762,615 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
multiple interactions |
ISO |
4 |
100,824,579 |
100,937,887 |
RGD:6480464 |
CTD |
| G |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
|
multiple interactions |
ISO |
7 |
51,846,256 |
51,860,121 |
RGD:6480464 |
CTD |
| G |
Kcnmb4 |
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
|
multiple interactions |
ISO |
10 |
115,854,924 |
115,910,579 |
RGD:6480464 |
CTD |
| G |
Kdm4b |
lysine (K)-specific demethylase 4B |
|
multiple interactions |
ISO |
17 |
56,465,473 |
56,542,296 |
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
multiple interactions |
ISO |
4 |
148,550,430 |
148,681,807 |
RGD:6480464 |
CTD |
| G |
Kin |
antigenic determinant of rec-A protein |
|
multiple interactions |
ISO |
2 |
10,002,239 |
10,014,328 |
RGD:6480464 |
CTD |
| G |
Klhl7 |
kelch-like 7 |
|
multiple interactions |
ISO |
5 |
23,606,408 |
23,667,049 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
ISO |
15 |
101,827,142 |
101,834,773 |
RGD:6480464 |
CTD |
| G |
Lamc1 |
laminin, gamma 1 |
|
multiple interactions |
ISO |
1 |
155,066,052 |
155,179,916 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
increases expression |
ISO |
2 |
158,132,229 |
158,158,588 |
RGD:6480464 |
CTD |
| G |
Letm2 |
leucine zipper-EF-hand containing transmembrane protein 2 |
|
decreases expression |
ISO |
8 |
26,688,962 |
26,707,959 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactose binding, soluble 3 |
|
increases expression |
ISO |
14 |
47,993,535 |
48,005,842 |
RGD:6480464 |
CTD |
| G |
Lhfp |
lipoma HMGIC fusion partner |
|
multiple interactions |
ISO |
3 |
52,845,469 |
53,065,601 |
RGD:6480464 |
CTD |
| G |
Lhfp |
lipoma HMGIC fusion partner |
|
decreases expression |
ISO |
3 |
52,845,469 |
53,065,601 |
RGD:6480464 |
CTD |
| G |
Limk1 |
LIM-domain containing, protein kinase |
|
multiple interactions |
ISO |
5 |
135,131,909 |
135,164,460 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
decreases expression |
ISO |
9 |
70,645,935 |
70,782,615 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
multiple interactions |
ISO |
7 |
26,164,546 |
26,181,006 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
increases activity |
ISO |
7 |
26,164,546 |
26,181,006 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
affects localization |
ISO |
7 |
26,164,546 |
26,181,006 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lrrc23 |
leucine rich repeat containing 23 |
|
multiple interactions |
ISO |
6 |
124,719,881 |
124,729,736 |
RGD:6480464 |
CTD |
| G |
Lst1 |
leukocyte specific transcript 1 |
|
increases expression |
ISO |
17 |
35,322,040 |
35,325,385 |
RGD:6480464 |
CTD |
| G |
Ltb |
lymphotoxin B |
|
multiple interactions |
ISO |
17 |
35,331,452 |
35,333,250 |
RGD:6480464 |
CTD |
| G |
Ltc4s |
leukotriene C4 synthase |
|
decreases secretion |
ISO |
11 |
50,049,974 |
50,051,973 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
decreases expression |
ISO |
9 |
110,921,796 |
110,945,270 |
RGD:6480464 |
CTD |
| G |
Lyplal1 |
lysophospholipase-like 1 |
|
multiple interactions |
ISO |
1 |
187,911,611 |
187,941,189 |
RGD:6480464 |
CTD |
| G |
Mapk1ip1l |
mitogen-activated protein kinase 1 interacting protein 1-like |
|
multiple interactions |
ISO |
14 |
47,917,989 |
47,942,766 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
multiple interactions |
ISO |
11 |
61,302,314 |
61,307,715 |
RGD:6480464 |
CTD |
| G |
Mdh1 |
malate dehydrogenase 1, NAD (soluble) |
|
multiple interactions |
ISO |
11 |
21,456,695 |
21,471,937 |
RGD:6480464 |
CTD |
| G |
Med13l |
mediator complex subunit 13-like |
|
multiple interactions |
ISO |
5 |
119,010,728 |
119,215,447 |
RGD:6480464 |
CTD |
| G |
Med16 |
mediator complex subunit 16 |
|
multiple interactions |
ISO |
10 |
79,357,452 |
79,371,683 |
RGD:6480464 |
CTD |
| G |
Mef2a |
myocyte enhancer factor 2A |
|
decreases expression |
ISO |
7 |
74,378,710 |
74,517,744 |
RGD:6480464 |
CTD |
| G |
Mettl15 |
methyltransferase like 15 |
|
multiple interactions |
ISO |
2 |
108,932,457 |
109,118,447 |
RGD:6480464 |
CTD |
| G |
Mfsd10 |
major facilitator superfamily domain containing 10 |
|
multiple interactions |
ISO |
5 |
34,976,296 |
34,979,763 |
RGD:6480464 |
CTD |
| G |
Milr1 |
mast cell immunoglobulin like receptor 1 |
|
decreases expression |
ISO |
11 |
106,612,582 |
106,628,882 |
RGD:6480464 |
CTD |
| G |
Mlf1ip |
myeloid leukemia factor 1 interacting protein |
|
multiple interactions |
ISO |
8 |
47,637,423 |
47,664,938 |
RGD:6480464 |
CTD |
| G |
Mmab |
methylmalonic aciduria (cobalamin deficiency) type B homolog (human) |
|
multiple interactions |
ISO |
5 |
114,881,043 |
114,894,036 |
RGD:6480464 |
CTD |
| G |
Mon1b |
MON1 homolog b (yeast) |
|
decreases expression |
ISO |
8 |
116,159,486 |
116,169,079 |
RGD:6480464 |
CTD |
| G |
Mphosph6 |
M phase phosphoprotein 6 |
|
multiple interactions |
ISO |
8 |
120,315,545 |
120,325,829 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
decreases expression |
ISO |
11 |
87,607,286 |
87,617,914 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
11 |
87,607,286 |
87,617,914 |
RGD:6480464 |
CTD |
| G |
Mtif3 |
mitochondrial translational initiation factor 3 |
|
multiple interactions |
ISO |
5 |
147,766,098 |
147,775,350 |
RGD:6480464 |
CTD |
| G |
Mto1 |
mitochondrial translation optimization 1 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
9 |
78,296,017 |
78,321,959 |
RGD:6480464 |
CTD |
| G |
Mug1 |
murinoglobulin 1 |
|
decreases expression |
ISO |
6 |
121,788,559 |
121,839,075 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
affects expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Mzt1 |
mitotic spindle organizing protein 1 |
|
decreases expression |
ISO |
14 |
99,433,763 |
99,445,355 |
RGD:6480464 |
CTD |
| G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
|
multiple interactions |
ISO |
5 |
151,438,548 |
151,468,187 |
RGD:6480464 |
CTD |
| G |
Nacc2 |
nucleus accumbens associated 2, BEN and BTB (POZ) domain containing |
|
increases expression |
ISO |
2 |
25,911,056 |
25,978,331 |
RGD:6480464 |
CTD |
| G |
Napepld |
N-acyl phosphatidylethanolamine phospholipase D |
|
multiple interactions |
ISO |
5 |
21,168,721 |
21,207,163 |
RGD:6480464 |
CTD |
| G |
Narg2 |
NMDA receptor-regulated gene 2 |
|
multiple interactions |
ISO |
9 |
69,245,805 |
69,280,881 |
RGD:6480464 |
CTD |
| G |
Nbeal1 |
neurobeachin like 1 |
|
multiple interactions |
ISO |
1 |
60,237,443 |
60,391,549 |
RGD:6480464 |
CTD |
| G |
Nck2 |
non-catalytic region of tyrosine kinase adaptor protein 2 |
|
multiple interactions |
ISO |
1 |
43,502,596 |
43,627,363 |
RGD:6480464 |
CTD |
| G |
Ndufb2 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 |
|
multiple interactions |
ISO |
6 |
39,520,009 |
39,553,417 |
RGD:6480464 |
CTD |
| G |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
|
increases expression |
ISO |
18 |
65,047,410 |
65,377,480 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
multiple interactions |
ISO |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
affects expression |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
decreases degradation |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nlk |
nemo like kinase |
|
multiple interactions |
ISO |
11 |
78,380,670 |
78,510,927 |
RGD:6480464 |
CTD |
| G |
Nnt |
nicotinamide nucleotide transhydrogenase |
|
multiple interactions |
ISO |
13 |
120,124,334 |
120,197,945 |
RGD:6480464 |
CTD |
| G |
Nomo1 |
nodal modulator 1 |
|
affects binding |
ISO |
7 |
53,289,066 |
53,339,582 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nqo2 |
NAD(P)H dehydrogenase, quinone 2 |
|
multiple interactions |
ISO |
13 |
34,056,528 |
34,080,334 |
RGD:6480464 |
CTD |
| G |
Nrep |
neuronal regeneration related protein |
|
decreases expression |
ISO |
18 |
33,596,673 |
33,623,683 |
RGD:6480464 |
CTD |
| G |
Nrxn3 |
neurexin III |
|
increases expression |
ISO |
12 |
90,191,834 |
91,573,375 |
RGD:6480464 |
CTD |
| G |
Nsun4 |
NOL1/NOP2/Sun domain family, member 4 |
|
increases expression |
ISO |
4 |
115,704,375 |
115,726,481 |
RGD:6480464 |
CTD |
| G |
Nts |
neurotensin |
|
multiple interactions |
ISO |
10 |
101,944,390 |
101,953,052 |
RGD:6480464 |
CTD |
| G |
Nup50 |
nucleoporin 50 |
|
multiple interactions |
ISO |
15 |
84,753,858 |
84,773,393 |
RGD:6480464 |
CTD |
| G |
Nutf2 |
nuclear transport factor 2 |
|
increases expression |
ISO |
8 |
108,384,534 |
108,404,302 |
RGD:6480464 |
CTD |
| G |
Ociad1 |
OCIA domain containing 1 |
|
multiple interactions |
ISO |
5 |
73,684,033 |
73,705,316 |
RGD:6480464 |
CTD |
| G |
Olfr732 |
olfactory receptor 732 |
|
increases expression |
ISO |
14 |
50,900,903 |
50,901,946 |
RGD:6480464 |
CTD |
| G |
Osbp |
oxysterol binding protein |
|
increases expression |
ISO |
19 |
12,040,334 |
12,068,604 |
RGD:6480464 |
CTD |
| G |
Otc |
ornithine transcarbamylase |
|
decreases expression |
ISO |
X |
9,829,485 |
9,898,150 |
RGD:6480464 |
CTD |
| G |
Otp |
orthopedia homolog (Drosophila) |
|
multiple interactions |
ISO |
13 |
95,645,582 |
95,653,636 |
RGD:6480464 |
CTD |
| G |
Pan3 |
PAN3 polyA specific ribonuclease subunit homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
5 |
148,242,156 |
148,360,077 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
affects binding |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Pcp4l1 |
Purkinje cell protein 4-like 1 |
|
multiple interactions |
ISO |
1 |
173,103,395 |
173,126,399 |
RGD:6480464 |
CTD |
| G |
Pcsk5 |
proprotein convertase subtilisin/kexin type 5 |
|
increases expression |
ISO |
19 |
17,507,322 |
17,912,122 |
RGD:6480464 |
CTD |
| G |
Pde3a |
phosphodiesterase 3A, cGMP inhibited |
|
increases expression |
ISO |
6 |
141,197,790 |
141,447,872 |
RGD:6480464 |
CTD |
| G |
Pdss2 |
prenyl (solanesyl) diphosphate synthase, subunit 2 |
|
multiple interactions |
ISO |
10 |
42,941,292 |
43,184,688 |
RGD:6480464 |
CTD |
| G |
Pea15a |
phosphoprotein enriched in astrocytes 15A |
|
decreases expression |
ISO |
1 |
174,126,860 |
174,136,912 |
RGD:6480464 |
CTD |
| G |
Pex7 |
peroxisomal biogenesis factor 7 |
|
multiple interactions |
ISO |
10 |
19,579,896 |
19,627,480 |
RGD:6480464 |
CTD |
| G |
Phf17 |
PHD finger protein 17 |
|
increases expression |
ISO |
3 |
41,359,656 |
41,420,786 |
RGD:6480464 |
CTD |
| G |
Pias1 |
protein inhibitor of activated STAT 1 |
|
multiple interactions |
ISO |
9 |
62,727,884 |
62,828,686 |
RGD:6480464 |
CTD |
| G |
Pias2 |
protein inhibitor of activated STAT 2 |
|
multiple interactions |
ISO |
18 |
77,303,947 |
77,394,447 |
RGD:6480464 |
CTD |
| G |
Picalm |
phosphatidylinositol binding clathrin assembly protein |
|
multiple interactions |
ISO |
7 |
97,278,742 |
97,357,442 |
RGD:6480464 |
CTD |
| G |
Pigc |
phosphatidylinositol glycan anchor biosynthesis, class C |
|
multiple interactions |
ISO |
1 |
163,899,319 |
163,903,566 |
RGD:6480464 |
CTD |
| G |
Pipox |
pipecolic acid oxidase |
|
decreases expression |
ISO |
11 |
77,694,117 |
77,707,374 |
RGD:6480464 |
CTD |
| G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
|
multiple interactions |
ISO |
5 |
111,759,783 |
111,817,379 |
RGD:6480464 |
CTD |
| G |
Pkhd1 |
polycystic kidney and hepatic disease 1 |
|
decreases expression |
ISO |
1 |
20,047,860 |
20,608,138 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase liver and red blood cell |
|
decreases expression |
ISO |
3 |
88,940,064 |
88,950,516 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 |
|
multiple interactions |
ISO |
2 |
134,611,900 |
135,300,994 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 |
|
decreases expression |
ISO |
2 |
134,611,900 |
135,300,994 |
RGD:6480464 |
CTD |
| G |
Pld3 |
phospholipase D family, member 3 |
|
increases expression |
ISO |
7 |
28,317,037 |
28,338,131 |
RGD:6480464 |
CTD |
| G |
Plekha1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
|
multiple interactions |
ISO |
7 |
138,009,424 |
138,056,816 |
RGD:6480464 |
CTD |
| G |
Plrg1 |
pleiotropic regulator 1, PRL1 homolog (Arabidopsis) |
|
increases expression |
ISO |
3 |
82,859,460 |
82,876,213 |
RGD:6480464 |
CTD |
| G |
Polr1b |
polymerase (RNA) I polypeptide B |
|
multiple interactions |
ISO |
2 |
128,926,732 |
128,952,331 |
RGD:6480464 |
CTD |
| G |
Polr2f |
polymerase (RNA) II (DNA directed) polypeptide F |
|
multiple interactions |
ISO |
15 |
78,971,797 |
78,982,197 |
RGD:6480464 |
CTD |
| G |
Polr3h |
polymerase (RNA) III (DNA directed) polypeptide H |
|
multiple interactions |
ISO |
15 |
81,745,460 |
81,756,643 |
RGD:6480464 |
CTD |
| G |
Polr3k |
polymerase (RNA) III (DNA directed) polypeptide K |
|
multiple interactions |
ISO |
2 |
181,599,065 |
181,605,535 |
RGD:6480464 |
CTD |
| G |
Pomc |
pro-opiomelanocortin-alpha |
|
multiple interactions |
ISO |
12 |
3,954,951 |
3,960,618 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
increases expression |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Ppp2ca |
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
|
decreases expression |
ISO |
11 |
51,912,326 |
51,936,251 |
RGD:6480464 |
CTD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isoform |
|
decreases expression |
ISO |
14 |
21,318,536 |
21,365,795 |
RGD:6480464 |
CTD |
| G |
Prim2 |
DNA primase, p58 subunit |
|
multiple interactions |
ISO |
1 |
33,510,656 |
33,726,603 |
RGD:6480464 |
CTD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
decreases expression |
ISO |
15 |
5,093,861 |
5,131,899 |
RGD:6480464 |
CTD |
| G |
Prkaca |
protein kinase, cAMP dependent, catalytic, alpha |
|
multiple interactions |
ISO |
8 |
86,496,877 |
86,520,344 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
decreases expression |
ISO |
11 |
107,794,701 |
108,205,202 |
RGD:6480464 |
CTD |
| G |
Prkra |
protein kinase, interferon inducible double stranded RNA dependent activator |
|
multiple interactions |
ISO |
2 |
76,467,994 |
76,486,051 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
multiple interactions |
ISO |
15 |
10,106,993 |
10,266,775 |
RGD:6480464 |
CTD |
| G |
Prpf38b |
PRP38 pre-mRNA processing factor 38 (yeast) domain containing B |
|
multiple interactions |
ISO |
3 |
108,705,725 |
108,714,622 |
RGD:6480464 |
CTD |
| G |
Psmb1 |
proteasome (prosome, macropain) subunit, beta type 1 |
|
affects expression |
ISO |
17 |
15,612,685 |
15,635,240 |
RGD:6480464 |
CTD |
| G |
Psmb10 |
proteasome (prosome, macropain) subunit, beta type 10 |
|
affects expression |
ISO |
8 |
108,459,628 |
108,462,292 |
RGD:6480464 |
CTD |
| G |
Psmb2 |
proteasome (prosome, macropain) subunit, beta type 2 |
|
affects expression |
ISO |
4 |
126,354,887 |
126,386,959 |
RGD:6480464 |
CTD |
| G |
Psmb5 |
proteasome (prosome, macropain) subunit, beta type 5 |
|
affects expression |
ISO |
14 |
55,232,957 |
55,236,832 |
RGD:6480464 |
CTD |
| G |
Psmb8 |
proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) |
|
affects expression |
ISO |
17 |
34,335,140 |
34,338,399 |
RGD:6480464 |
CTD |
| G |
Psmb9 |
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) |
|
affects expression |
ISO |
17 |
34,319,044 |
34,324,275 |
RGD:6480464 |
CTD |
| G |
Ptma |
prothymosin alpha |
|
decreases expression |
ISO |
1 |
88,423,311 |
88,427,273 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase 4a1 |
|
decreases expression |
ISO |
1 |
30,997,148 |
31,006,600 |
RGD:6480464 |
CTD |
| G |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
|
increases expression |
ISO |
18 |
67,825,155 |
67,884,275 |
RGD:6480464 |
CTD |
| G |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
|
increases expression |
ISO |
7 |
142,729,507 |
142,877,977 |
RGD:6480464 |
CTD |
| G |
Pycr2 |
pyrroline-5-carboxylate reductase family, member 2 |
|
multiple interactions |
ISO |
1 |
182,834,405 |
182,838,219 |
RGD:6480464 |
CTD |
| G |
Rab11b |
RAB11B, member RAS oncogene family |
|
increases expression |
ISO |
17 |
33,879,429 |
33,897,431 |
RGD:6480464 |
CTD |
| G |
Rab21 |
RAB21, member RAS oncogene family |
|
multiple interactions |
ISO |
10 |
114,726,918 |
114,752,647 |
RGD:6480464 |
CTD |
| G |
Rad9a |
RAD9 homolog A |
|
decreases expression |
ISO |
19 |
4,195,198 |
4,201,603 |
RGD:6480464 |
CTD |
| G |
Rangrf |
RAN guanine nucleotide release factor |
|
increases expression |
ISO |
11 |
68,785,989 |
68,787,322 |
RGD:6480464 |
CTD |
| G |
Rasal2 |
RAS protein activator like 2 |
|
decreases expression |
ISO |
1 |
159,065,314 |
159,342,726 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
14 |
73,595,309 |
73,725,598 |
RGD:6480464 |
CTD |
| G |
Rbm8a |
RNA binding motif protein 8a |
|
multiple interactions |
ISO |
3 |
96,433,851 |
96,437,714 |
RGD:6480464 |
CTD |
| G |
Rc3h1 |
RING CCCH (C3H) domains 1 |
|
multiple interactions |
ISO |
1 |
162,836,542 |
162,905,107 |
RGD:6480464 |
CTD |
| G |
Rcan1 |
regulator of calcineurin 1 |
|
increases expression |
ISO |
16 |
92,392,198 |
92,466,391 |
RGD:6480464 |
CTD |
| G |
Rdh10 |
retinol dehydrogenase 10 (all-trans) |
|
increases expression |
ISO |
1 |
16,095,963 |
16,122,631 |
RGD:6480464 |
CTD |
| G |
Reck |
reversion-inducing-cysteine-rich protein with kazal motifs |
|
multiple interactions |
ISO |
4 |
43,888,402 |
43,957,678 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects localization |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Ren1 |
renin 1 structural |
|
affects expression |
ISO |
1 |
135,247,251 |
135,256,894 |
RGD:6480464 |
CTD |
| G |
Rfk |
riboflavin kinase |
|
multiple interactions |
ISO |
19 |
17,468,533 |
17,475,839 |
RGD:6480464 |
CTD |
| G |
Rftn1 |
raftlin lipid raft linker 1 |
|
multiple interactions |
ISO |
17 |
50,132,632 |
50,329,822 |
RGD:6480464 |
CTD |
| G |
Rgs16 |
regulator of G-protein signaling 16 |
|
increases expression |
ISO |
1 |
155,587,483 |
155,592,598 |
RGD:6480464 |
CTD |
| G |
Rhno1 |
RAD9-HUS1-RAD1 interacting nuclear orphan 1 |
|
multiple interactions |
ISO |
6 |
128,307,018 |
128,312,915 |
RGD:6480464 |
CTD |
| G |
Rhot2 |
ras homolog gene family, member T2 |
|
multiple interactions |
ISO |
17 |
25,975,783 |
25,981,796 |
RGD:6480464 |
CTD |
| G |
Ric3 |
resistance to inhibitors of cholinesterase 3 homolog (C. elegans) |
|
affects binding |
ISO |
7 |
116,177,833 |
116,226,838 |
RGD:6480464 |
CTD |
| G |
Riok3 |
RIO kinase 3 |
|
decreases expression |
ISO |
18 |
12,287,359 |
12,315,876 |
RGD:6480464 |
CTD |
| G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
|
multiple interactions |
ISO |
14 |
56,403,832 |
56,407,694 |
RGD:6480464 |
CTD |
| G |
Rmnd5a |
required for meiotic nuclear division 5 homolog A (S. cerevisiae) |
|
multiple interactions |
ISO |
6 |
71,338,628 |
71,390,631 |
RGD:6480464 |
CTD |
| G |
Rnaset2a |
ribonuclease T2A |
|
multiple interactions |
ISO |
17 |
8,321,463 |
8,340,653 |
RGD:6480464 |
CTD |
| G |
Rps15 |
ribosomal protein S15 |
|
decreases expression |
ISO |
10 |
79,755,176 |
79,756,859 |
RGD:6480464 |
CTD |
| G |
Sbspon |
somatomedin B and thrombospondin, type 1 domain containing |
|
decreases expression |
ISO |
1 |
15,843,943 |
15,882,803 |
RGD:6480464 |
CTD |
| G |
Sco2 |
SCO cytochrome oxidase deficient homolog 2 (yeast) |
|
multiple interactions |
ISO |
15 |
89,202,068 |
89,204,249 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
increases expression |
ISO |
5 |
120,926,556 |
120,933,914 |
RGD:6480464 |
CTD |
| G |
Secisbp2 |
SECIS binding protein 2 |
|
multiple interactions |
ISO |
13 |
51,747,083 |
51,779,015 |
RGD:6480464 |
CTD |
| G |
Sell |
selectin, lymphocyte |
|
multiple interactions |
ISO |
1 |
165,992,207 |
166,010,916 |
RGD:6480464 |
CTD |
| G |
Setd2 |
SET domain containing 2 |
|
decreases expression |
ISO |
9 |
110,435,101 |
110,521,137 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant associated protein B |
|
multiple interactions |
ISO |
6 |
72,253,239 |
72,264,364 |
RGD:6480464 |
CTD |
| G |
Sh2d2a |
SH2 domain protein 2A |
|
multiple interactions |
ISO |
3 |
87,650,677 |
87,659,644 |
RGD:6480464 |
CTD |
| G |
Shprh |
SNF2 histone linker PHD RING helicase |
|
multiple interactions |
ISO |
10 |
10,869,228 |
10,935,072 |
RGD:6480464 |
CTD |
| G |
Sirt2 |
sirtuin 2 (silent mating type information regulation 2, homolog) 2 (S. cerevisiae) |
|
multiple interactions |
ISO |
7 |
29,551,771 |
29,573,684 |
RGD:6480464 |
CTD |
| G |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
|
multiple interactions |
ISO |
16 |
33,518,415 |
33,664,221 |
RGD:6480464 |
CTD |
| G |
Slc12a9 |
solute carrier family 12 (potassium/chloride transporters), member 9 |
|
multiple interactions |
ISO |
5 |
137,755,786 |
137,774,810 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16 (monocarboxylic acid transporters), member 1 |
|
multiple interactions |
ISO |
3 |
104,442,591 |
104,462,385 |
RGD:6480464 |
CTD |
| G |
Slc25a24 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24 |
|
multiple interactions |
ISO |
3 |
108,926,067 |
108,971,327 |
RGD:6480464 |
CTD |
| G |
Slc39a9 |
solute carrier family 39 (zinc transporter), member 9 |
|
increases expression |
ISO |
12 |
81,745,202 |
81,784,329 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases expression |
ISO |
8 |
73,406,788 |
73,416,656 |
RGD:6480464 |
CTD |
| G |
Slco1b2 |
solute carrier organic anion transporter family, member 1b2 |
|
increases expression |
ISO |
6 |
141,578,039 |
141,635,156 |
RGD:6480464 |
CTD |
| G |
Slmap |
sarcolemma associated protein |
|
multiple interactions |
ISO |
14 |
27,232,661 |
27,353,226 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
multiple interactions |
ISO |
18 |
76,401,579 |
76,465,385 |
RGD:6480464 |
CTD |
| G |
Smad5 |
SMAD family member 5 |
|
multiple interactions |
ISO |
13 |
56,804,371 |
56,843,739 |
RGD:6480464 |
CTD |
| G |
Smek2 |
SMEK homolog 2, suppressor of mek1 (Dictyostelium) |
|
multiple interactions |
ISO |
11 |
29,072,907 |
29,120,797 |
RGD:6480464 |
CTD |
| G |
Smim7 |
small integral membrane protein 7 |
|
multiple interactions |
ISO |
8 |
75,089,097 |
75,094,947 |
RGD:6480464 |
CTD |
| G |
Smu1 |
smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans) |
|
increases expression |
ISO |
4 |
40,682,682 |
40,704,918 |
RGD:6480464 |
CTD |
| G |
Snap23 |
synaptosomal-associated protein 23 |
|
multiple interactions |
ISO |
2 |
120,393,407 |
120,426,458 |
RGD:6480464 |
CTD |
| G |
Snx13 |
sorting nexin 13 |
|
multiple interactions |
ISO |
12 |
35,731,861 |
35,832,149 |
RGD:6480464 |
CTD |
| G |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
|
decreases expression |
ISO |
1 |
57,831,705 |
58,005,241 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
ISO |
11 |
60,012,591 |
60,034,106 |
RGD:6480464 |
CTD |
| G |
Srr |
serine racemase |
|
decreases expression |
ISO |
11 |
74,719,861 |
74,739,300 |
RGD:6480464 |
CTD |
| G |
Srsf3 |
serine/arginine-rich splicing factor 3 |
|
multiple interactions |
ISO |
17 |
29,169,618 |
29,180,311 |
RGD:6480464 |
CTD |
| G |
Ssr1 |
signal sequence receptor, alpha |
|
decreases expression |
ISO |
13 |
38,063,270 |
38,086,059 |
RGD:6480464 |
CTD |
| G |
Ssr3 |
signal sequence receptor, gamma |
|
increases expression |
ISO |
3 |
65,183,579 |
65,196,475 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
increases secretion |
ISO |
16 |
23,889,667 |
23,890,930 |
RGD:6480464 |
CTD |
| G |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
|
multiple interactions |
ISO |
4 |
117,604,758 |
117,807,519 |
RGD:6480464 |
CTD |
| G |
Stam2 |
signal transducing adaptor molecule (SH3 domain and ITAM motif) 2 |
|
multiple interactions |
ISO |
2 |
52,547,725 |
52,601,183 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 |
|
increases expression |
ISO |
11 |
100,748,124 |
100,800,825 |
RGD:6480464 |
CTD |
| G |
Stk24 |
serine/threonine kinase 24 |
|
multiple interactions |
ISO |
14 |
121,685,563 |
121,778,452 |
RGD:6480464 |
CTD |
| G |
Stk35 |
serine/threonine kinase 35 |
|
multiple interactions |
ISO |
2 |
129,626,253 |
129,658,023 |
RGD:6480464 |
CTD |
| G |
Supt6 |
suppressor of Ty 6 |
|
decreases expression |
ISO |
11 |
78,020,251 |
78,059,205 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin 1 |
|
multiple interactions |
ISO |
6 |
7,505,071 |
7,512,973 |
RGD:6480464 |
CTD |
| G |
Taf1a |
TATA box binding protein (Tbp)-associated factor, RNA polymerase I, A |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tars2 |
threonyl-tRNA synthetase 2, mitochondrial (putative) |
|
multiple interactions |
ISO |
3 |
95,543,897 |
95,558,900 |
RGD:6480464 |
CTD |
| G |
Tas2r140 |
taste receptor, type 2, member 140 |
|
multiple interactions |
ISO |
6 |
133,004,873 |
133,005,811 |
RGD:6480464 |
CTD |
| G |
Tbca |
tubulin cofactor A |
|
increases expression |
ISO |
13 |
95,558,898 |
95,612,854 |
RGD:6480464 |
CTD |
| G |
Tbxas1 |
thromboxane A synthase 1, platelet |
|
multiple interactions |
ISO |
6 |
38,868,985 |
39,034,578 |
RGD:6480464 |
CTD |
| G |
Tcf3 |
transcription factor 3 |
|
multiple interactions |
ISO |
10 |
79,871,910 |
79,896,398 |
RGD:6480464 |
CTD |
| G |
Tcn2 |
transcobalamin 2 |
|
increases expression |
ISO |
11 |
3,817,080 |
3,832,081 |
RGD:6480464 |
CTD |
| G |
Tefm |
transcription elongation factor, mitochondrial |
|
multiple interactions |
ISO |
11 |
79,950,180 |
79,955,655 |
RGD:6480464 |
CTD |
| G |
Tesk1 |
testis specific protein kinase 1 |
|
increases expression |
ISO |
4 |
43,455,149 |
43,460,947 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgif1 |
TGFB-induced factor homeobox 1 |
|
increases expression |
ISO |
17 |
71,193,545 |
71,202,872 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
decreases expression |
ISO |
7 |
104,561,467 |
104,566,020 |
RGD:6480464 |
CTD |
| G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
|
increases expression |
ISO |
X |
20,447,292 |
20,451,863 |
RGD:6480464 |
CTD |
| G |
Tmc5 |
transmembrane channel-like gene family 5 |
|
multiple interactions |
ISO |
7 |
125,740,811 |
125,818,599 |
RGD:6480464 |
CTD |
| G |
Tmed4 |
transmembrane emp24 protein transport domain containing 4 |
|
multiple interactions |
ISO |
11 |
6,170,717 |
6,174,840 |
RGD:6480464 |
CTD |
| G |
Tmem106b |
transmembrane protein 106B |
|
multiple interactions |
ISO |
6 |
13,019,759 |
13,039,269 |
RGD:6480464 |
CTD |
| G |
Tmem19 |
transmembrane protein 19 |
|
decreases expression |
ISO |
10 |
114,777,795 |
114,799,318 |
RGD:6480464 |
CTD |
| G |
Tmem243 |
transmembrane protein 243, mitochondrial |
|
multiple interactions |
ISO |
5 |
9,100,737 |
9,118,983 |
RGD:6480464 |
CTD |
| G |
Tmem260 |
transmembrane protein 260 |
|
multiple interactions |
ISO |
14 |
49,066,027 |
49,134,834 |
RGD:6480464 |
CTD |
| G |
Tmem63a |
transmembrane protein 63a |
|
decreases expression |
ISO |
1 |
182,872,649 |
182,905,235 |
RGD:6480464 |
CTD |
| G |
Tmem80 |
transmembrane protein 80 |
|
multiple interactions |
ISO |
7 |
148,514,029 |
148,523,054 |
RGD:6480464 |
CTD |
| G |
Tmem87b |
transmembrane protein 87B |
|
multiple interactions |
ISO |
2 |
128,644,039 |
128,679,997 |
RGD:6480464 |
CTD |
| G |
Tmx3 |
thioredoxin-related transmembrane protein 3 |
|
increases expression |
ISO |
18 |
90,679,546 |
90,712,659 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
|
multiple interactions |
ISO |
18 |
50,139,081 |
50,252,883 |
RGD:6480464 |
CTD |
| G |
Tpmt |
thiopurine methyltransferase |
|
increases expression |
ISO |
13 |
47,118,912 |
47,138,586 |
RGD:6480464 |
CTD |
| G |
Tpp2 |
tripeptidyl peptidase II |
|
multiple interactions |
ISO |
1 |
43,990,852 |
44,059,816 |
RGD:6480464 |
CTD |
| G |
Traf1 |
TNF receptor-associated factor 1 |
|
decreases expression |
ISO |
2 |
34,798,778 |
34,817,292 |
RGD:6480464 |
CTD |
| G |
Trmt10a |
tRNA methyltransferase 10A |
|
multiple interactions |
ISO |
3 |
137,806,502 |
137,822,785 |
RGD:6480464 |
CTD |
| G |
Trmt10a |
tRNA methyltransferase 10A |
|
decreases expression |
ISO |
3 |
137,806,502 |
137,822,785 |
RGD:6480464 |
CTD |
| G |
Trmt61a |
tRNA methyltransferase 61A |
|
multiple interactions |
ISO |
12 |
112,916,316 |
112,922,113 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
decreases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
decreases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
multiple interactions |
ISO |
2 |
126,617,294 |
126,701,997 |
RGD:6480464 |
CTD |
| G |
Ttc3 |
tetratricopeptide repeat domain 3 |
|
multiple interactions |
ISO |
16 |
94,592,346 |
94,690,828 |
RGD:6480464 |
CTD |
| G |
Ttc37 |
tetratricopeptide repeat domain 37 |
|
decreases expression |
ISO |
13 |
76,236,182 |
76,325,431 |
RGD:6480464 |
CTD |
| G |
Ttll3 |
tubulin tyrosine ligase-like family, member 3 |
|
affects binding |
ISO |
6 |
113,339,254 |
113,364,577 |
RGD:6480464 |
CTD |
| G |
Ttn |
titin |
|
multiple interactions |
ISO |
2 |
76,542,041 |
76,820,604 |
RGD:6480464 |
CTD |
| G |
Tuba1b |
tubulin, alpha 1B |
|
multiple interactions |
ISO |
15 |
98,761,860 |
98,764,821 |
RGD:6480464 |
CTD |
| G |
Tubd1 |
tubulin, delta 1 |
|
multiple interactions |
ISO |
11 |
86,358,510 |
86,380,862 |
RGD:6480464 |
CTD |
| G |
Tusc3 |
tumor suppressor candidate 3 |
|
increases expression |
ISO |
8 |
40,068,921 |
40,193,932 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
increases expression |
EXP |
7 |
94,575,915 |
94,641,921 |
RGD:6480464 |
CTD |
| G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
|
affects expression |
ISO |
X |
20,235,547 |
20,260,305 |
RGD:6480464 |
CTD |
| G |
Ube2d3 |
ubiquitin-conjugating enzyme E2D 3 |
|
affects expression |
ISO |
3 |
135,101,723 |
135,130,142 |
RGD:6480464 |
CTD |
| G |
Ubfd1 |
ubiquitin family domain containing 1 |
|
multiple interactions |
ISO |
7 |
129,210,712 |
129,225,713 |
RGD:6480464 |
CTD |
| G |
Ubqln2 |
ubiquilin 2 |
|
increases expression |
ISO |
X |
149,932,775 |
149,936,105 |
RGD:6480464 |
CTD |
| G |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
|
multiple interactions |
ISO |
11 |
102,165,874 |
102,180,410 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
|
affects expression |
ISO |
5 |
67,067,360 |
67,078,473 |
RGD:6480464 |
CTD |
| G |
Ufm1 |
ubiquitin-fold modifier 1 |
|
multiple interactions |
ISO |
3 |
53,659,131 |
53,667,729 |
RGD:6480464 |
CTD |
| G |
Ugt2b35 |
UDP glucuronosyltransferase 2 family, polypeptide B35 |
|
decreases expression |
ISO |
5 |
87,429,885 |
87,442,299 |
RGD:6480464 |
CTD |
| G |
Ugt2b38 |
UDP glucuronosyltransferase 2 family, polypeptide B38 |
|
decreases expression |
ISO |
5 |
87,838,964 |
87,853,228 |
RGD:6480464 |
CTD |
| G |
Utp15 |
UTP15, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
|
increases expression |
ISO |
13 |
99,016,800 |
99,032,947 |
RGD:6480464 |
CTD |
| G |
Uvrag |
UV radiation resistance associated gene |
|
multiple interactions |
ISO |
7 |
106,035,253 |
106,289,654 |
RGD:6480464 |
CTD |
| G |
Vegfc |
vascular endothelial growth factor C |
|
increases expression |
ISO |
8 |
55,162,886 |
55,271,808 |
RGD:6480464 |
CTD |
| G |
Vps26a |
vacuolar protein sorting 26 homolog A (yeast) |
|
multiple interactions |
ISO |
10 |
61,917,591 |
61,949,553 |
RGD:6480464 |
CTD |
| G |
Vsx1 |
visual system homeobox 1 homolog (zebrafish) |
|
multiple interactions |
ISO |
2 |
150,506,438 |
150,514,873 |
RGD:6480464 |
CTD |
| G |
Wbscr16 |
Williams-Beuren syndrome chromosome region 16 homolog (human) |
|
multiple interactions |
ISO |
5 |
134,623,928 |
134,652,637 |
RGD:6480464 |
CTD |
| G |
Wdr20a |
WD repeat domain 20A |
|
multiple interactions |
ISO |
12 |
111,976,159 |
112,033,238 |
RGD:6480464 |
CTD |
| G |
Wdr20b |
WD repeat domain 20b |
|
multiple interactions |
ISO |
12 |
66,326,504 |
66,329,441 |
RGD:6480464 |
CTD |
| G |
Wdyhv1 |
WDYHV motif containing 1 |
|
multiple interactions |
ISO |
15 |
57,972,991 |
57,990,209 |
RGD:6480464 |
CTD |
| G |
Whsc1l1 |
Wolf-Hirschhorn syndrome candidate 1-like 1 (human) |
|
multiple interactions |
ISO |
8 |
26,712,778 |
26,830,139 |
RGD:6480464 |
CTD |
| G |
Wtap |
Wilms' tumour 1-associating protein |
|
multiple interactions |
ISO |
17 |
13,159,665 |
13,185,405 |
RGD:6480464 |
CTD |
| G |
Wwox |
WW domain-containing oxidoreductase |
|
multiple interactions |
ISO |
8 |
116,963,552 |
117,876,612 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
increases expression |
ISO |
X |
39,421,013 |
39,462,841 |
RGD:6480464 |
CTD |
| G |
Xylb |
xylulokinase homolog (H. influenzae) |
|
multiple interactions |
ISO |
9 |
119,266,499 |
119,302,438 |
RGD:6480464 |
CTD |
| G |
Yap1 |
yes-associated protein 1 |
|
decreases expression |
ISO |
9 |
7,931,999 |
8,004,596 |
RGD:6480464 |
CTD |
| G |
Yipf4 |
Yip1 domain family, member 4 |
|
multiple interactions |
ISO |
17 |
74,888,854 |
74,899,617 |
RGD:6480464 |
CTD |
| G |
Yipf6 |
Yip1 domain family, member 6 |
|
increases expression |
ISO |
X |
96,133,120 |
96,144,360 |
RGD:6480464 |
CTD |
| G |
Ythdc1 |
YTH domain containing 1 |
|
increases expression |
ISO |
5 |
87,233,515 |
87,265,682 |
RGD:6480464 |
CTD |
| G |
Zbtb18 |
zinc finger and BTB domain containing 18 |
|
multiple interactions |
ISO |
1 |
179,374,792 |
179,380,895 |
RGD:6480464 |
CTD |
| G |
Zbtb25 |
zinc finger and BTB domain containing 25 |
|
multiple interactions |
ISO |
12 |
77,449,887 |
77,470,547 |
RGD:6480464 |
CTD |
| G |
Zbtb45 |
zinc finger and BTB domain containing 45 |
|
multiple interactions |
ISO |
7 |
13,591,015 |
13,595,149 |
RGD:6480464 |
CTD |
| G |
Zcchc10 |
zinc finger, CCHC domain containing 10 |
|
multiple interactions |
ISO |
11 |
53,138,191 |
53,146,803 |
RGD:6480464 |
CTD |
| G |
Zdhhc11 |
zinc finger, DHHC domain containing 11 |
|
decreases expression |
ISO |
13 |
74,101,310 |
74,130,288 |
RGD:6480464 |
CTD |
| G |
Zfand3 |
zinc finger, AN1-type domain 3 |
|
multiple interactions |
ISO |
17 |
30,142,032 |
30,346,965 |
RGD:6480464 |
CTD |
| G |
Zfp191 |
zinc finger protein 191 |
|
multiple interactions |
ISO |
18 |
24,170,768 |
24,179,272 |
RGD:6480464 |
CTD |
| G |
Zfp354a |
zinc finger protein 354A |
|
multiple interactions |
ISO |
11 |
50,872,759 |
50,886,301 |
RGD:6480464 |
CTD |
| G |
Zfp788 |
zinc finger protein 788 |
|
multiple interactions |
ISO |
7 |
48,888,901 |
48,906,904 |
RGD:6480464 |
CTD |
| G |
Zfpl1 |
zinc finger like protein 1 |
|
multiple interactions |
ISO |
19 |
6,080,762 |
6,084,891 |
RGD:6480464 |
CTD |
| G |
Zrsr2 |
zinc finger (CCCH type), RNA binding motif and serine/arginine rich 2 |
|
decreases expression |
ISO |
X |
160,373,375 |
160,396,598 |
RGD:6480464 |
CTD |
| G |
Zxdc |
ZXD family zinc finger C |
|
multiple interactions |
ISO |
6 |
90,319,488 |
90,353,480 |
RGD:6480464 |
CTD |
Term paths to the root
|